Ashford Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,950
Closed -$238K 111
2020
Q3
$238K Sell
3,950
-1,000
-20% -$60.2K 0.03% 91
2020
Q2
$291K Buy
+4,950
New +$296K 0.04% 87
2019
Q1
Sell
-6,596
Closed -$343K 98
2018
Q4
$343K Hold
6,596
0.06% 101
2018
Q3
$409K Hold
6,596
0.05% 97
2018
Q2
$365K Hold
6,596
0.05% 97
2018
Q1
$417K Hold
6,596
0.06% 82
2017
Q4
$404K Hold
6,596
0.06% 85
2017
Q3
$420K Hold
6,596
0.07% 87
2017
Q2
$368K Hold
6,596
0.06% 87
2017
Q1
$359K Hold
6,596
0.07% 91
2016
Q4
$385K Hold
6,596
0.08% 84
2016
Q3
$356K Hold
6,596
0.07% 92
2016
Q2
$485K Hold
6,596
0.11% 81
2016
Q1
$421K Hold
6,596
0.1% 90
2015
Q4
$454K Buy
6,596
+400
+6% +$26.4K 0.11% 87
2015
Q3
$367K Hold
6,196
0.09% 99
2015
Q2
$412K Hold
6,196
0.09% 101
2015
Q1
$400K Sell
6,196
-5,527
-47% -$346K 0.08% 104
2014
Q4
$692K Hold
11,723
0.14% 98
2014
Q3
$600K Hold
11,723
0.13% 98
2014
Q2
$569K Hold
11,723
0.11% 104
2014
Q1
$609K Hold
11,723
0.12% 102
2013
Q4
$623K Hold
11,723
0.12% 98
2013
Q3
$543K Hold
11,723
0.11% 103
2013
Q2
$524K Buy
+11,723
New +$509K 0.11% 101

Other funds holding BMY

Ashford Capital Management's BMY Position: Q4 2020 in Review

Ashford Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 3,950 shares — an estimated $238K sold.

Ashford Capital Management first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $692K in Q4 2014. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Ashford Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Ashford Capital Management sold 3,950 Bristol-Myers Squibb shares in Q4 2020, an estimated $238K.
  • Ashford Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
  • Ashford Capital Management's Bristol-Myers Squibb position peaked at $692K in Q4 2014.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Ashford Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.